ID   MO1043
AC   CVCL_Y383
SY   Mo1043
DR   Wikidata; Q54906283
RX   PubMed=8412300;
RX   PubMed=19358282;
CC   Misspelling: M01043; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
RX   PubMed=19358282; DOI=10.1002/ijc.24351;
RA   Inagaki, Atsushi
RA   Ishida, Takashi
RA   Yano, Hiroki
RA   Ishii, Toshihiko
RA   Kusumoto, Shigeru
RA   Ito, Asahi
RA   Ri, Masaki
RA   Mori, Fumiko
RA   Ding, Jian-Min
RA   Komatsu, Hirokazu
RA   Iida, Shinsuke
RA   Ueda, Ryuzo
RT   "Expression of the ULBP ligands for NKG2D by B-NHL cells plays an
RT   important role in determining their susceptibility to
RT   rituximab-induced ADCC.";
RL   Int. J. Cancer 125:212-221(2009).
//
RX   PubMed=8412300; DOI=10.1016/0145-2126(93)90154-D;
RA   Kawata, Akira
RA   Han, Tin
RA   Dadey, Barbara
RA   Weier, Heinz-Ulrich Gunter
RA   Okazaki, Morihiro
RA   Yokota, Soichiro
RA   Fukiage, Tadahiro
RA   Xiao, Han
RA   Block, AnneMarie W.
RA   Barcos, Maurice P.
RA   Henderson, Edward
RA   Yoshida, Minoru
RA   Seon, Ben K.
RT   "Establishment and characterization of the tumors of chronic
RT   lymphocytic leukemia cell line in nude and SCID mice.";
RL   Leuk. Res. 17:883-894(1993).
//